Target intelligence / Profile preview

Micro-deformation of the wound bed (MDWT)

Target
MDWT
Molecular classification
Mechanical stimulus, Biomechanical process, Other
01

Overview

Micro-deformation of the wound bed refers to the microscopic mechanical stretching and distortion of cells and the extracellular matrix induced by Negative Pressure Wound Therapy (NPWT) [1, 10]. This phenomenon occurs when sub-atmospheric pressure is applied across a porous dressing (such as polyurethane foam), causing the underlying tissue to be pulled into the dressing pores and creating localized micromechanical strain [2, 8]. This physical stress triggers mechanotransduction, a process where cells convert mechanical signals into biochemical cascades, leading to the upregulation of healing-related genes and growth factors like VEGF and TGF-beta1 [6, 9]. These signals promote critical healing activities, including cell proliferation, migration, and the rapid formation of vascularized granulation tissue [3, 5]. While micro-deformation is a biomechanical mechanism rather than a discrete molecular target, it serves as the functional basis for advanced wound care devices to treat chronic or non-healing ulcers [4, 7]. Optimizing these micromechanical forces is essential for treating conditions like diabetic foot ulcers and pressure sores where standard healing processes have stalled [11, 18].

Other names
Micromechanical strainTissue micro-deformationMicromechanical forceMicrostrainMicro-deformation
02

Mechanism of action

Micro-deformation activates mechanotransduction pathways, converting physical tissue strain into biochemical signals such as growth factor release and ion channel activation to drive cell proliferation and tissue remodeling [6, 8, 10].

03

Biological functions

Signal transductionCell proliferationCell migrationAngiogenesisGranulation tissue formationMechanotransduction
04

Disease associations

InflammationChronic woundDiabetic foot ulcerPressure ulcerSurgical woundComplex soft-tissue injury
05

Safety considerations

Bleeding [7]Pain during dressing change [7]Tissue necrosis [7]Toxic shock syndrome [7]Fistula formation [7]
06

Interacting drugs

Negative Pressure Wound Therapy (NPWT) systems

3 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF) [2, 8]Transforming growth factor beta 1 (TGF-beta1) [8]Matrix metalloproteinases (MMPs) [12, 14]Granulation tissue thickness [3, 5]Tissue perfusion [1, 14]

Beyond the preview

Go deeper on Micro-deformation of the wound bed (MDWT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micro-deformation of the wound bed (MDWT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call